Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2003
02/06/2003US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027981 Urokinase-type plasminogen activator receptor
02/06/2003US20030027779 Method for inducing DNA synthesis in neurons
02/06/2003US20030027768 For therapy of diseases and conditions mediated by undesired and uncontrolled cell invasion and/or angiogenesis
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors
02/06/2003US20030027751 For promoting angiogenesis, bone growth, wound healing
02/06/2003US20030027340 Insertion sequence element derived from Ralstonia solanacearum
02/06/2003US20030027320 Promoters for regulated gene expression
02/06/2003US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases
02/06/2003US20030027313 Cloned genes encoding reverse transcriptase lacking RNase H activity
02/06/2003US20030027312 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants
02/06/2003US20030027311 Recombinant anti-tumor RNAse
02/06/2003US20030027310 Enzymatic polypeptide for use in preventing the development of biofilms
02/06/2003US20030027309 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis
02/06/2003US20030027308 Novel human protein phosphatases identified from genomic sequencing
02/06/2003US20030027307 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/06/2003US20030027306 Alcohol dehydrogenase for use in the generation of amino alcohols
02/06/2003US20030027305 Pyruvate carboxylase from Corynebacterium glutamicum
02/06/2003US20030027304 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030027303 Nucleotide sequences coding enzyme inhibitors for use in biological pest control
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027298 Enzyme mixture for use in the food processing, textiles treatment, paper making, pest control, wood prservatives and topical lotions
02/06/2003US20030027296 Cloned dna polymerases from thermotoga maritima and mutants thereof
02/06/2003US20030027295 Nucleotide sequences coding enzymatic polypeptide for use in the generation insecticides
02/06/2003US20030027290 For producing glucose from starch
02/06/2003US20030027289 Kit for use in the generation of preferential expression vectors
02/06/2003US20030027285 Genetically engineered cells for use in the generation of fluorescent proteins
02/06/2003US20030027282 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
02/06/2003US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027268 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027258 Methods and compositions for pearl oyster cultivation
02/06/2003US20030027257 Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
02/06/2003US20030027256 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
02/06/2003US20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
02/06/2003US20030027249 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of non-insulin dependent diadetes mellitus, tumous, infection, skin disorders and inflammatory bowel disease
02/06/2003US20030027237 Serine-threonine phosphatase protein of a parasitic organism of the apicomplexa phylum, applications in therapeutics
02/06/2003US20030027224 Monitoring immunosuppressive activity of compound; obtain sample containing calmodulin dependent kinase, incubate with substrate, expose to modulator, monitor phosphorylation, reduction in phosphorylation indicates suppressive activity
02/06/2003US20030027212 Antibody for use in tissue classification
02/06/2003US20030027209 Binding polypeptide; for use in treatment and diagnosis of cancer, infections or autoimmune disease
02/06/2003US20030027191 Polynucleotides encoding insect ethanolamine kinase and uses thereof
02/06/2003US20030027165 Nucleotide sequences sequences coding polypeptide for use in the treatment and diagnosis of autoimmune, cancer and apoptosis diseases
02/06/2003US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins
02/06/2003US20030027150 Method of haplotyping and kit therefor
02/06/2003US20030027146 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027145 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027144 Nucleotide sequences coding protein for use in the treatment cancer
02/06/2003US20030027143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027124 Genetically engineering cell structure; obtain cells, amplify intracellular concentration of preferential enzymatic polypeptide, monitor structure of cell
02/06/2003US20030026810 Novel rhamnogalacturonan hydrolases
02/06/2003US20030026799 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030026798 In situ dissolving of deposits
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026795 Methods and compositions for controlling insects
02/06/2003US20030026784 Cardiovascular disorders; genetic engineered mouse
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
02/06/2003CA2454701A1 Nucleic acid sequences encoding enantioselective amidases
02/06/2003CA2454342A1 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003CA2451430A1 Genes involved in the biosynthesis of isopentenyl diphosphate in hevea brasiliensis latex
02/05/2003EP1281775A2 Identification and use of molecules implicated in pain
02/05/2003EP1281771A2 Phosphodiesterase 10A cell-based assay and sequences
02/05/2003EP1281770A2 Human brain phosphodiesterase and screening method
02/05/2003EP1281762A2 Luciferases
02/05/2003EP1281756A1 Regulator of calcineurin
02/05/2003EP1281755A2 Variants of the human cyp2d6 gene
02/05/2003EP1280930A1 Gamma secretase substrates and in vitro assays
02/05/2003EP1280928A2 Resistance to acetohydroxyacid synthase-inhibiting herbicides
02/05/2003EP1280927A2 Corynebacterium glutamicum strain with enhanced secretion activity
02/05/2003EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
02/05/2003EP1280923A2 14094, a human trypsin family member and uses thereof
02/05/2003EP1280922A2 21953, a human prolyl oligopeptidase family member and uses thereof
02/05/2003EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
02/05/2003EP1280920A2 Phytase polypeptides
02/05/2003EP1280919A2 Lipolytic enzyme variants
02/05/2003EP1280918A2 Lipid metabolism enzymes
02/05/2003EP1280917A2 21657, a human short-chain dehydrogenase and uses thereof
02/05/2003EP1280916A2 26343, a novel human oxidoreductase and uses therefor
02/05/2003EP1280915A1 23155 novel protein human 5-alpha reductases and uses therefor
02/05/2003EP1280892A2 ISOLATION AND EXPRESSION OF A GENE FOR A NITRILASE FROM i ACIDOVORAX FACILIS 72W
02/05/2003EP1280890A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
02/05/2003EP1280820A2 Anti-inflammatory compounds and uses thereof
02/05/2003EP1280817A2 Production and use of protein variants having modified immunogenecity
02/05/2003EP1280764A2 Inhibitors of histone deacetylase
02/05/2003EP1280511A1 Stabilised enzyme compositions
02/05/2003EP1280404A2 Model for neurodegenerative disease
02/05/2003EP1280398A2 Stress-related potassium channel proteins and their uses in plants
02/05/2003EP1280397A2 Transcription factor stress-related proteins and methods of use in plants
02/05/2003EP0907723A4 Enzyme composition for tissue dissociation
02/05/2003EP0892813A4 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
02/05/2003EP0794787B1 Compositions for the treatment of parasitic and fungal infections
02/05/2003EP0574512B1 Redirection of cellular immunity by receptor chimeras
02/05/2003CN1395618A Production of five-carbon sugars and sugar alcohols